Novel manifestations of immune dysregulation and granule defects in gray platelet syndromeMatthew C. Sims, Ernest Turro, Paolo Gresele et al.|Blood|2020Cited by 60
Why patients with THBD c.1611C>A (p.Cys537X) nonsense mutation have high levels of soluble thrombomodulin?Yohann Jourdy, Yesim Dargaud, Sandra Le Quellec et al.|PLoS ONE|2017Cited by 11
Effect of five therapeutic strategies on the coagulation defect induced by the thrombomodulin c.1611C>A mutationYesim Dargaud, Claude Négrier, Sandra Le Quellec et al.|British Journal of Haematology|2015Cited by 6
The potential value of thrombin generation assay in the diagnosis of FV inhibitorsStéphanie Desage, Yohann Jourdy, Christophe Nougier et al.|International Journal of Laboratory Hematology|2019Cited by 2
Single‐center determination of reference factor II and factor X activity level values for the monitoring of vitamin K antagonist therapyStéphanie Desage, Yohann Jourdy, Christophe Nougier et al.|International Journal of Laboratory Hematology|2019Cited by 2